Gilead generates $10 billion annually from Sovaldi, and a little over $3 billion a quarter from Harvoni. Expectations are that the market for Epclusa will mimic that of Sovaldi initially and then expand based on its presence in international markets and the benefit for the full sweep treatment it offers
This is a quote from a press release today....If the author is even close in projections, why the continued selling like all things current and in he future pipeline will drop off?
Polls are not that far apart. Trump is growing. Hilary is shrinking for now. So many people have no idea why they do not like Trump. When they tune into the debates and actually listen to policy positions, enough voters will turn. Than I thought Romnet was a shoe-in.
watch an see. Most people have not listed to a speech yet, only sound bites. He will infer mthe uninformed during debates. Watch it all change quickly
I did the ssame yesterday and left 50 cents on the table than reloaded today on mark down. Enough traders on ws do not trust any move in the bio sector regardless of a company specific story like gild has.
until earnings and commentary from cc/guidance, this sector and stock are still on shaky grounds it seems
Also look at Rome for more clues. Nevertheless, neither example is needed. Trump will claim this by wide margin. Momentum favors him and he has not even begun his campaign against HRC. Once they start the debates, he will inform the uninformed and stupid people who remain clueless about her doings and their foundation. Unlike Romney who quite after the first debate, Trump will destroy her.
Just out on barons.com. This was final sentence in report.
Across the board.
did nem run too high or is there a player on ws kicking this in the butt on runs?
maybe my imagination is running wild?
Earnings date does not come quick enough.
Got back in at 5.66 yesterday after market drop in the indexes and gold did not impact CLF SP that much. For 2016 I have only traded CLF (multiple times) for gains to chip away at prior losses the previous 2 years.
The run up to $6 was strong and the trickle down selling in bad markets for CLF is showing me real relative strength to keep trading. Maybe I will go long again at some point, but I was burnt enough in the past not to trust things for very long.
On June1, in his most recent interview he said the ArcMittal contract was simply a roll over and it does not stabilize CLF finances.
In May he used CLF guidance for production on a $35MT cost basis then said CLF will generate $205M in EBITDA against a cost of $305M.
While he has been right about CLF for years, he seems to be doubling down here and is jeopardizing a very good record until 2016. Nothing in his YTD calls played out so far. Nothing.
Strength in IO prices and the demand has surprised me. The numbers for CLF must be revised higher going into earnings. For Gordo's numbers to play out for remainder of 2016, there has to be a dramatic change in both variables (selling price significantly lowered as well as demand cratering). I think demand will be even larger than what LG guided to last qtr.
This will be a remarkable beat for CLF this qtr.
The CC will be interesting when LG challenges analysts again on their assumptions.
i said many of these points myself before Tuesday but I disagree here. With news of the approval on last Tuesday they could have produced a release to disclose something of value. last qtr earnings brought SP down $20 on sales concerns since May. They had great opportunity Tuesday to press that concern but did not. SP is down $40 from 12 months ago and now hovering on the lows. Last Tuesday was a great time but that time is now lost.
not sure if this find was reason NEM sold down from 40.99 high today. ABX is up along with GDX, GLD and GOLD. Regardless, it is holding in and could catch another bid and stronger gold prices and crumbling everything else.
I just picked up another position today near lows for another move up.
The sector is just dead. GILD management, for whatever reasons, seems to think there is nothing to say.
give it some time. GILD seemed to trade better than the IBB last week on the up and downside and today the markets hoeing hit along with the IBB. GILD may be separating itself as a stock specific story, not an indexer sector story. Need time to confirm this, but that is what it looked like last week.
Amazing what an exp day can do to a stock
I also closed out my trading and IRA positions on Friday. Will wait for confirmation of trend or pull back to reload. The run was largely uninterupted and everything macro still scares me, and our 10 year bond does not portend a stronger economy. This could be the 5th qtr of bad S&P earnings.
GILD has a good story looking forward on all things Hep C, its pipeline, the buyback and more.
Whatever gets her moving up is okay with me.
I picked up a new stake today for another trade in MXL. The buying interest just disappeared but for the past 5 sessions, share price stopped falling and started trickling up. I hope the buyers return soon. Interest in buying or selling MXL of late is limited on both sides of the trade
A very once week for GILD